Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For ALL
NCT00500240Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Apr 2004
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin aspart, insulin glargine in hyperglycemia, sponsored by University of Texas MD Anderson Cancer Center. Started Apr 2004; status: terminated.
02
Drugs
insulin aspartinsulin glargine
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT00500240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00500240.